RESMED INC (RMD)

SEC fundamentals · as filed in 10-K FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Other listed symbols of this issuer: RSMDF

Verified against EDGAR
Total Assets
$8.97B
Stockholders' Equity
$6.59B
Cash & Equivalents
$1.47B
Long-Term Debt
$399.4M

as filed in 10-K FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-K for the period ended Jun 30, 2026, RESMED INC reported revenue of $5.65B, net income of $1.52B, and total assets of $8.97B. Every figure below is taken directly from RESMED INC's SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2017–FY2026 · as reported

$5.65B$2.98B$315.6M
FY2017FY2020FY2023FY2026
Revenue$5.65BNet income$1.52B
FY2017 revenue
$2.07B
FY2026 revenue
$5.65B

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2026$5.65B$1.52B
FY2025$5.15B$1.40B
FY2024$4.69B$1.02B
FY2023$4.22B$897.6M
FY2022$3.58B$779.4M
FY2021$3.20B$474.5M
FY2020$2.96B$621.7M
FY2019$2.61B$404.6M
FY2018$2.34B$315.6M
FY2017$2.07B$342.3M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 29, 2026on EDGAR ↗
DEF 14AOct 1, 2026on EDGAR ↗
8-KSep 1, 2026on EDGAR ↗
8-KAug 17, 2026on EDGAR ↗
10-KAug 13, 2026on EDGAR ↗
8-KAug 6, 2026on EDGAR ↗
8-KJul 7, 2026on EDGAR ↗
10-QMay 1, 2026on EDGAR ↗
8-KApr 30, 2026on EDGAR ↗
8-KApr 30, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-K

Total Assets$8.97Bsource ↗
Stockholders’ Equity$6.59Bsource ↗
Cash & Equivalents$1.47Bsource ↗
Long-Term Debt$399.4Msource ↗

Income Statement

10-K (annual) · period ended Jun 30, 2026

Revenue$5.65Bsource ↗
Net Income$1.52Bsource ↗
Operating Income$1.89Bsource ↗
Gross Profit$3.45Bsource ↗
Cost of Revenue$2.20Bsource ↗
R&D Expense$378.3Msource ↗

Per Share & Cash Flow

10-K (annual) · period ended Jun 30, 2026

EPS (diluted)$10.43source ↗
EPS (basic)$10.47source ↗
Shares Outstanding144.3Msource ↗
Cash from Operations$1.81Bsource ↗
Cash from Financing-$1.01Bsource ↗
Cash from Investing-$545.2Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
9
Net shares
-39.3K

Restatement history

Point-in-time

7 of 612 annual fact-keys were materially restated between filings: what RESMED INC first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches RMD’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/RMD

MCP tool: get_sec_fundamentals ticker=RMD

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/RMD/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=RMD as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/RMD/history

MCP tool: get_fundamentals_history ticker=RMD

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/RMD

MCP tool: get_financial_health ticker=RMD

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.